PB Fintech Ltd

The transcript on page 17 of the document does not mention any current or planned future fundraising through debt or equity. Key points are: - No explicit mention of raising debt or equity capital during the call. - Focus is on building risk capabilities, scaling unsecured lending with FLDG partnerships, and expanding collections capability. - Management highlights internal growth plans and operational efficiencies rather than external fundraising. - Cash balance mentioned is ₹5,400 Cr, indicating a healthy liquidity position. - No statements suggest immediate need or plans for raising capital through debt or equity. Therefore, as per the transcript, there is no indication of new fundraising through debt or equity in the near term.

- The company has recently completed a round of funding and acquired one asset, with plans to acquire 3-4 more assets. - Specifically in healthcare, they are targeting acquisition of 2-3 operating hospitals and 2-3 "shells" which will be rapidly converted to operating hospitals in the NCR region. - Investment focus includes adding doctors and hospital-building experts alongside tech and product teams. - In credit business, there is an emphasis on expanding secured lending (home loans, loans against property and cars) and building capabilities like PB Money to support savings and better risk underwriting. - Management indicates ongoing investments in AI and technology to improve operational efficiency, such as AI agents for collections and customer service automation. - No mention of immediate large-scale capex figures, but clear strategic investments in healthcare assets, secured lending infrastructure, and technology enhancement are planned or underway.

- Core business expected to grow at ~30% CAGR over the long term, considered the planning benchmark. - Health insurance is currently outperforming with 4-5x industry growth in new business acquisition, exceeding expectations. - Term insurance grows steadily at 12-15% industry rate; company grows multiples faster than this. - Credit business showing good month-on-month growth; confident about future expansion, especially secured lending. - Savings segment presently challenged with slowdown, expected to remain slow for initial quarters of the new fiscal year; diversification and new products are key focus areas. - Deep tech (AI) anticipated to significantly impact customer service within 1-3 years; sales impact expected over a 3-year horizon. - Overall growth driven by increasing renewals and fresh business, with sustained operational efficiencies.

- PB Fintech expects a long-term revenue CAGR of about 30%, based on management guidance and historical performance (Page 11). - Core business has been growing at a 43% CAGR over the past five years, ahead of initial expectations (Page 11). - Health insurance growth is notably strong, currently achieving 4-5x industry growth rates for new business acquisition (Page 10). - Renewals contribute high profitability with consistent margin expansion expected as renewal book grows (Page 5). - Fresh health business growth, while profitable growth dampening currently, is seen as a cause for celebration likely to improve margin contribution over time (Page 5). - New initiatives are improving from negative margins towards positive contribution but remain at small margins currently (Page 5). - Core business EBITDA margin is stable around 16%, with new initiatives improving from -1% to +4% recently (Page 11). - PB Fintech projects sustained profitability with improved operating margins and expects credit and healthcare businesses to grow steadily (Pages 10-11).

The transcript does not explicitly mention current or expected orderbook/pending orders. However, relevant insights related to business investments and asset acquisitions include: - The company has acquired one asset and is planning to acquire 3-4 more assets, focusing on hospitals in the NCR region. - Plans to buy 2-3 operating hospitals and 2-3 shells to convert into operating hospitals. - Strategy involves a mix of existing revenue/profits and new builds. - The healthcare business is described as a long-term project with ongoing weekly reviews but no rapid changes expected. No specific figures or direct mentions of orderbook or pending orders are provided in the transcript.